Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
national blog main
san diego blog main
6
×
biotech
life sciences
boston blog main
san diego top stories
seattle blog main
startups
boston top stories
fda
indiana blog main
medtech
new york blog main
raleigh-durham blog main
san francisco blog main
venture capital
boston
boulder/denver blog main
clinical trials
deals
detroit blog main
medical device
national
national top stories
people
roboticsai
san diego
software
tech
texas blog main
texas top stories
vc
wisconsin blog main
abide therapeutics
accent therapeutics
acquisition
aducanumab
allergan
alzheimer's disease
amblyotech
What
developing
6
×
company
medicines
ipo
medical
million
startup
therapeutics
abide
activity
appointed
approvals
based
beta
bio
biogen
bionics
blood
brings
business
carlsmed
chief
clamped
closed
comes
control
covid
delays
device
diabetes
diego
diseases
disorders
driven
drug
dyne
dyne’s
economic
effect
execs
Language
unset
unknown
Current search:
xconomy.com
×
developing
×
" san diego blog main "
×
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
@xconomy.com
4 years ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com
4 years ago
Spine-Surgery Medtech Startup Carlsmed Merges With Imaging Company
@xconomy.com
5 years ago
Former Zavante Executive Tapped as Abide Therapeutics President
@xconomy.com
5 years ago
Beta Bionics Secures $63M as AI-Driven “Pancreas” Heads to Key Tests
@xconomy.com
5 years ago
From Immigration to Taxes, Execs Talk Trump Effect on Innovation